Evidence map›Paper›PMID 30895941›Full record

ArticleJCI insight2019

Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.

Tessa Dhaeze, Catherine Lachance, Laurence Tremblay, Camille Grasmuck, Lyne Bourbonnière, Sandra Larouche, Olivia Saint-Laurent, Marc-André Lécuyer, Rose-Marie Rébillard, Stephanie Zandee and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Biological Sex As a Critical Variable in CD4Antioxidants & redox signaling · 2022
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tessa DhaezeNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Catherine LachanceNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Laurence TremblayNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Camille GrasmuckNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Lyne BourbonnièreNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Sandra LaroucheNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Olivia Saint-LaurentNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Marc-André LécuyerNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Rose-Marie RébillardNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Stephanie ZandeeNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Alexandre PratNeuroimmunology Unit, Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de recherche du CHUM (CRCHUM), Montréal, Québec, Canada.
Centre Hospitalier de l’Université de Montréal · CA

Funding

CIHR MOP 89885CIHR PJI-153195
6 · The paper itself

Abstract

TCR1640 mice, which have a T cell receptor (TCR) directed against MOG92-106, spontaneously develop experimental autoimmune encephalomyelitis. Female mice mostly develop a relapsing-remitting (RR) course and have a higher incidence of disease, while males most frequently suffer from progressive disease, reflecting the unresolved clinical sex discrepancies seen in multiple sclerosis. Herein, we performed adoptive transfers of male and female TCR1640 immune cells into WT animals to investigate if disease course is dependent on the sex of the donor immune cells or on the sex of the recipient animal. We found that transfer of female TCR1640 immune cells led to a RR disease while transfer of male TCR1640 immune cells led to a progressive course, independent of the sex of the recipient. In addition, regulatory and pathogenic T cell infiltration after transfer was also immune cell sex intrinsic. We performed genetic profiling of the donor immune cells and found significant differences between the transcriptomic profiles of male and female TCR1640 immune cells, interestingly, within genes related to immune regulation of T lymphocytes. These results suggest that differences in gene expression profiles related to regulation of T cell immunity seen in male and female neuroinflammatory disease drive relapsing versus progressive disease course.

Indexed as

Disease ProgressionAdoptive TransferAnimalsAutoimmune DiseasesBlood-Brain BarrierDemyelinating DiseasesDisease Models, AnimalFemaleImmunologic FactorsMaleMiceMice, TransgenicMultiple SclerosisPhenotypeReceptors, Antigen, T-CellRecurrenceImmunologic FactorsReceptors, Antigen, T-CellAutoimmune diseasesAutoimmunityExpression profilingMultiple sclerosisNeuroscience

Identifiers

PMID30895941
PMCPMC6483003
OpenAlexW2937961994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.